(Stock Symbol: CBSC) is a Rising Entry into the Multi-Billion Dollar Cardiac Monitoring Medical Device and Technology Software Field with FDA and CE Cleared Products & Technology

March 08 21:40 2021
(Stock Symbol: CBSC) is a Rising Entry into the Multi-Billion Dollar Cardiac Monitoring Medical Device and Technology Software Field with FDA and CE Cleared Products & Technology

CB Scientific, Inc, Stock Symbol – CBSC 

COVID was officially declared a national emergency on March 13, 2020. Immediately, according to OnlineDoctor, Google search interest for “telehealth” rose by 317%. Simultaneously, Google searches for the term “doctor near me” dropped by 28% in the U.S. Now that it’s clear Americans are open to at home healthcare services it’s up to us as investors to find great companies in this space for our portfolios. I have identified two such companies and this article will introduce them as well as support my opinion that investing in At Home Healthcare companies should result in a huge profit potential. 

A new wave of enthusiasm for ‘no contact’ medicine has taken hold in the United States and it’s in the form of telemedicine and at home remote monitoring. For patients that are at high risk of Covid-19, going to the doctor’s office can be mixed with fear and concern of contracting the illness due to the high likelihood of human contact. Telemedicine and at home remote monitoring are both solutions to deal with that anxiety.  Telemedicine and at home remote monitoring both significantly reduces the risk of Covid-19 exposure.  As a result, many Americans are adopting a positive attitude toward new technology for being treated and diagnosed at home. 

Telehealth is the distribution of health-related services and information via electronic information and telecommunication technologies. It allows long-distance patient and clinician contact, care, advice, reminders, education, intervention, monitoring, and remote admissions according to Wikipedia

CB Scientific Inc, CBSC, a public company trading under the stock ticker CBSC is focused on at home remote monitoring. These two featured companies will reiterate the foundational argument of this article which is that medicine in the future is going to be strongly footed in Telemedicine and at home remote monitoring. Companies that are on the forefront today are sure to be leaders in the industry tomorrow and to that end, I as the writer and as an investor feel there is a tremendous opportunity to make money with developing companies that personify why at home medical services are an essential part of any portfolio containing healthcare related investments.  


CB Scientific Inc, Stock Symbol CBSC, provides innovative products and services in the ambulatory non-invasive cardiac remote monitoring space. Their FDA and CE cleared EKG devices, interactive cloud-based acquisition software, and smartphone apps for both iOS and Android platforms, provide improvements in compliance for patients at risk of abnormal heart rhythms as well as more scientifically accurate information for physicians. (*) in customer trials awaiting final CFDA approval. Recently the company announced they are closing an acquisition (https://cbscientificinc.com/cb-scientific-inc-announces-definitive-agreement-to-acquire-cardiolink-corporation-an-independent-diagnostic-testing-facility-idtf/) which will streamline their diagnostics by offering both a diagnosis and treatment recommendations. CBSC has also announced that they have new Asian distributors for their My-Cam product, an auto trigger loop EKG recording device. With that development, the company then appointed a new director of Asia Pacific and Chip Martin as the CEO for CBSC.  This is discussed in a recent podcast  (https://audioboom.com/posts/7807543-cb-scientific-inc-discusses-the-potential-of-their-proprietary-cardiac-event-monitor-my-cam-w) including future revenue projections by June 2021. 

CB Scientific Inc. (Stock Symbol CBSC) could be quite undervalued. When they start delivering product(s) to their new Asian distributors later this month, we will see just how impactful their non invasive cardiac monitor is for people all over the world. Asia, in particular, has a particularly high rate of heart disease and globally it already effects 31% of the world’s population. CBSC is positioned perfectly to help change early detection and diagnosis which will save lives and costs due to heart disease. 

We have heard from Doctors like Ami Shah, a board certified and fellowship trained internal medicine physician who has practiced telemedicine for over 15 years, who believes whole heartily that Telemedicine is the future and at home remote monitoring is absolutely an integral part of the overall picture for optimal health and well-being.


FrontPageStocks/CorporateAds.com (CA) is a third-party publisher and news dissemination service provider. FPS/CA is NOT affiliated in any manner with any company mentioned herein. FPS/CA is news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FPS/CA’s market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release or opinion of the writer. FPS/ CA is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. FPS/CA has been compensated $500 by the company for dissemination of this Article.

Disclaimer/Safe Harbor:

These news releases and postings may contain forward-looking statements within the meaning of the Securities Litigation Reform Act. The statements reflect the Company’s current views with respect to future events that involve risks and uncertainties. Among others, these risks include the expectation that any of the companies mentioned herein will achieve significant sales, the failure to meet schedule or performance requirements of the companies’ contracts, the companies’ liquidity position, the companies’ ability to obtain new contracts, the emergence of competitors with greater financial resources and the impact of competitive pricing. In the light of these uncertainties, the forward-looking events referred to in this release might not occur.

Media Contact
Company Name: CB Scientific, Inc.
Contact Person: Media Relations
Email: Send Email
Phone: 888-225-0870
Address:340 State Place
City: Escondido
State: CA 92029
Country: United States
Website: www.cbscientificinc.com